# Vitalant – FDA Inspection, Apr 18, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/28a89513-b90a-4ba4-a459-011efca7d337
Source feed: FDA_Inspections

> FDA inspection 1009225 of Vitalant, April 18, 2017. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009225
- Company Name: Vitalant
- Inspection Date: 2017-04-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1278748 - 2025-07-22](https://www.keypedia.com/records/fda_inspections/vitalant/c8f242bc-99e0-41e4-9b5c-5cf25be85d25)
- FDA Inspection 1211673 - 2023-08-02
- FDA Inspection 1101239 - 2019-07-16
- FDA Inspection 899398 - 2014-10-08
- FDA Inspection 805484 - 2012-10-31

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/vitalant/cc782b46-8d7e-44d6-b03e-42f305c87c06

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d